type here...

CATEGORIES

Healthcare

LATEST

1...464748...75Page 47 of 75

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Uninsured Children; Time for Us to Help Kids Get Access to High-Quality Healthcare

Dr Jeff Livingston -
Many US children qualify for high-quality healthcare through the Medicaid and CHIP programs. Here, we show families how to apply to these programs.

Research on Controlling Cellular Outposts of the Immune System

Medika Life -
New RNA research. The miR-424(322)/503 gene cluster regulates pro- vs anti-inflammatory skin DC subset differentiation by modulating TGF-beta signaling

Like Dark Chocolate or Black Coffee? Here’s Why

Michael Hunter, MD -
I LIKE DARK, ARGUABLY BITTER CHOCOLATE. If you join me in this preference, you are more likely to prefer your coffee black. New research suggests...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories